Brian D Moore1, Dallas Hyde, Lisa Miller, Emily Wong, Jessica Frelinger, Edward S Schelegle. 1. Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, and Respiratory Diseases Unit, California National Primate Research Center, University of California - Davis, Davis, CA 95616-8732, USA. brimoore@ucdavis.edu
Abstract
BACKGROUND: Serotonin (5-HT) modulates cholinergic neurotransmission and exacerbates airway smooth muscle (ASM) contraction in normal animal and nonasthmatic human tissue. Exposure to house dust mite allergen (HDMA) and ozone (O(3)) leads to airway hyperreactivity and 5-HT-positive cells in the airway epithelium of infant rhesus monkeys. Research shows that concomitant exposure in allergic animals has an additive effect on airway hyperreactivity. OBJECTIVES: In this study, the hypothesis is that the exposure of allergic infant rhesus monkeys to HDMA, O(3) and in combination, acting through 5-HT receptors, enhances 5-HT modulation of postganglionic cholinergic ASM contraction. METHODS: Twenty-four HDMA-sensitized infant monkeys were split into 4 groups at the age of 1 month, and were exposed to filtered air (FA), HDMA, O(3) or in combination (HDMA+O(3)). At the age of 6 months, airway rings were harvested and postganglionic, and parasympathetic-mediated ASM contraction was evaluated using electrical-field stimulation (EFS). RESULTS: 5-HT exacerbated the EFS response within all exposure groups, but had no effect in the FA group. 5-HT(2), 5-HT(3) and 5-HT(4) receptor agonists exacerbated the response. 5-HT concentration-response curves performed after incubation with specific receptor antagonists confirmed the involvement of 5-HT(2), 5-HT(3) and 5-HT(4) receptors. Conversely, a 5-HT(1) receptor agonist attenuated the tension across all groups during EFS, and in ASM contracted via exogenous acetylcholine. CONCLUSIONS: HDMA, O(3) and HDMA+O(3) exposure in a model of childhood allergic asthma enhances 5-HT exacerbation of EFS-induced ASM contraction through 5-HT(2), 5-HT(3) and 5-HT(4) receptors. A nonneurogenic inhibitory pathway exists, unaffected by exposure, mediated by 5-HT(1) receptors located on ASM.
BACKGROUND:Serotonin (5-HT) modulates cholinergic neurotransmission and exacerbates airway smooth muscle (ASM) contraction in normal animal and nonasthmatic human tissue. Exposure to house dust mite allergen (HDMA) and ozone (O(3)) leads to airway hyperreactivity and 5-HT-positive cells in the airway epithelium of infantrhesus monkeys. Research shows that concomitant exposure in allergic animals has an additive effect on airway hyperreactivity. OBJECTIVES: In this study, the hypothesis is that the exposure of allergicinfantrhesus monkeys to HDMA, O(3) and in combination, acting through 5-HT receptors, enhances 5-HT modulation of postganglionic cholinergic ASM contraction. METHODS: Twenty-four HDMA-sensitized infant monkeys were split into 4 groups at the age of 1 month, and were exposed to filtered air (FA), HDMA, O(3) or in combination (HDMA+O(3)). At the age of 6 months, airway rings were harvested and postganglionic, and parasympathetic-mediated ASM contraction was evaluated using electrical-field stimulation (EFS). RESULTS: 5-HT exacerbated the EFS response within all exposure groups, but had no effect in the FA group. 5-HT(2), 5-HT(3) and 5-HT(4) receptor agonists exacerbated the response. 5-HT concentration-response curves performed after incubation with specific receptor antagonists confirmed the involvement of 5-HT(2), 5-HT(3) and 5-HT(4) receptors. Conversely, a 5-HT(1) receptor agonist attenuated the tension across all groups during EFS, and in ASM contracted via exogenous acetylcholine. CONCLUSIONS: HDMA, O(3) and HDMA+O(3) exposure in a model of childhood allergic asthma enhances 5-HT exacerbation of EFS-induced ASM contraction through 5-HT(2), 5-HT(3) and 5-HT(4) receptors. A nonneurogenic inhibitory pathway exists, unaffected by exposure, mediated by 5-HT(1) receptors located on ASM.
Authors: Rob McConnell; Kiros Berhane; Frank Gilliland; Stephanie J London; Talat Islam; W James Gauderman; Edward Avol; Helene G Margolis; John M Peters Journal: Lancet Date: 2002-02-02 Impact factor: 79.321
Authors: R D Youssefyeh; H F Campbell; S Klein; J E Airey; P Darkes; M Powers; M Schnapper; K Neuenschwander; L R Fitzpatrick; C E Pendley Journal: J Med Chem Date: 1992-03-06 Impact factor: 7.446
Authors: Stephanie J London; Wei Gao; Sina A Gharib; Dana B Hancock; Jemma B Wilk; John S House; Richard A Gibbs; Donna M Muzny; Thomas Lumley; Nora Franceschini; Kari E North; Bruce M Psaty; Christie L Kovar; Josef Coresh; Yanhua Zhou; Susan R Heckbert; Jennifer A Brody; Alanna C Morrison; Josée Dupuis Journal: Circ Cardiovasc Genet Date: 2014-06
Authors: Shannon R Murphy; Karen L Oslund; Dallas M Hyde; Lisa A Miller; Laura S Van Winkle; Edward S Schelegle Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-07-25 Impact factor: 5.464
Authors: Candace M Crowley; Justin H Fontaine; Joan E Gerriets; Edward S Schelegle; Dallas M Hyde; Lisa A Miller Journal: Toxicol Appl Pharmacol Date: 2017-05-18 Impact factor: 4.219
Authors: Brian D Moore; Dallas M Hyde; Lisa A Miller; Emily M Wong; Edward S Schelegle Journal: Am J Respir Cell Mol Biol Date: 2014-07 Impact factor: 6.914
Authors: Shannon R Murphy; Edward S Schelegle; Lisa A Miller; Dallas M Hyde; Laura S Van Winkle Journal: Toxicol Sci Date: 2013-04-09 Impact factor: 4.849
Authors: Xiaoling Gu; Philip H Karp; Steven L Brody; Richard A Pierce; Michael J Welsh; Michael J Holtzman; Yehuda Ben-Shahar Journal: Am J Respir Cell Mol Biol Date: 2014-03 Impact factor: 6.914
Authors: Cameron H Flayer; Erik D Larson; Anjali Joseph; Sean Kao; Wenxiu Qu; Austin Van Haren; Christopher M Royer; Lisa A Miller; John P Capitanio; Thais Sielecki; Melpo Christofidou-Solomidou; Angela Haczku Journal: J Allergy Clin Immunol Date: 2019-10-15 Impact factor: 10.793